Orion Portfolio Solutions LLC lowered its stake in STERIS plc (NYSE:STE - Free Report) by 39.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 14,205 shares of the medical equipment provider's stock after selling 9,357 shares during the period. Orion Portfolio Solutions LLC's holdings in STERIS were worth $2,920,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Franklin Resources Inc. lifted its stake in STERIS by 171.2% during the third quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider's stock worth $191,370,000 after purchasing an additional 529,308 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of STERIS by 30.8% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 10,970 shares of the medical equipment provider's stock worth $2,275,000 after buying an additional 2,583 shares in the last quarter. Wilmington Savings Fund Society FSB bought a new stake in shares of STERIS during the 3rd quarter worth $9,949,000. Public Sector Pension Investment Board boosted its stake in STERIS by 13.2% in the third quarter. Public Sector Pension Investment Board now owns 4,283 shares of the medical equipment provider's stock valued at $1,039,000 after buying an additional 500 shares in the last quarter. Finally, Merit Financial Group LLC bought a new position in STERIS in the fourth quarter valued at about $260,000. Institutional investors and hedge funds own 94.69% of the company's stock.
Wall Street Analyst Weigh In
A number of research analysts have recently commented on the stock. Stephens reissued an "overweight" rating and issued a $240.00 target price on shares of STERIS in a report on Thursday, February 6th. JMP Securities reissued a "market outperform" rating and issued a $265.00 price objective on shares of STERIS in a research note on Thursday, February 6th. Finally, Piper Sandler boosted their target price on shares of STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a research note on Monday, February 3rd. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $258.75.
Get Our Latest Report on STE
STERIS Trading Down 3.7 %
Shares of STERIS stock traded down $8.25 on Friday, hitting $213.16. The stock had a trading volume of 1,201,030 shares, compared to its average volume of 533,170. The stock has a 50 day moving average of $223.23 and a 200 day moving average of $220.57. The firm has a market capitalization of $20.94 billion, a P/E ratio of 45.26 and a beta of 0.87. STERIS plc has a twelve month low of $197.82 and a twelve month high of $248.24. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13.
STERIS (NYSE:STE - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. Sell-side analysts expect that STERIS plc will post 9.08 earnings per share for the current fiscal year.
STERIS Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were paid a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.07%. The ex-dividend date was Thursday, February 20th. STERIS's dividend payout ratio is currently 48.41%.
STERIS Profile
(
Free Report)
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
Featured Stories
Before you consider STERIS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and STERIS wasn't on the list.
While STERIS currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
